Skip to content

Call for patient input on inebilizumab (Uplizna®) for immunoglobulin G4-related disease

If you live with immunoglobulin G4-related disease or care for someone with immunoglobulin G4-related disease, please send us your input by March 19, 2026. Your input will be anonymous. All questions require an answer. Write N/A if it does not apply to you.
1.Are you a patient living with immunoglobulin G4-related disease or a caregiver to someone living with immunoglobulin G4-related disease?(Required.)